2月26日，百济神州（688235）股价盘中最高触及230元/股，涨幅超4%，创历史新高。2024年前三季度，公司实现营收191.36亿元，同比增长48.63%；归母净利润-36.87亿元，同比增长4.94%。核心产品泽布替尼（百悦泽）2024年前三季度全球销售额达18.16亿美元（约129亿元人民币），同比增长107%，占公司总营收67.7%。替雷利珠单抗（百泽安）成为首个获FDA批准的国产PD...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.